scholarly journals US College Students Are at Increased Risk for Serogroup B Meningococcal Disease

2019 ◽  
Vol 9 (2) ◽  
pp. 244-247 ◽  
Author(s):  
Gary S Marshall ◽  
Amanda F Dempsey ◽  
Amit Srivastava ◽  
Raul E Isturiz

Abstract Publicly available surveillance data, Centers for Disease Control and Prevention reports, and other sources suggest that college students in the United States are at increased risk for meningococcus serogroup B (MenB) disease. US surveillance data from 2015 to 2017 show that the incidence of invasive meningococcal disease (IMD) was greater among college students than among those not attending college; the average annual incidence of MenB disease was >5-fold higher among college students, and all college IMD outbreaks between 2011 and March 2019 were caused by MenB.

PEDIATRICS ◽  
1996 ◽  
Vol 97 (5) ◽  
pp. 607-612
Author(s):  
Naomi Wortis ◽  
Peter M. Strebel ◽  
Melinda Wharton ◽  
Barbara Bardenheier ◽  
Iain R. B. Hardy

Objective. To characterize pertussis deaths and to identify possible risk factors and prevention strategies. Methods. A retrospective review of all deaths attributed to pertussis with disease onset during 1992 and 1993 reported to the Centers for Disease Control and Prevention. Hospital discharge summaries and autopsy reports were reviewed, and additional clinical information was provided by physicians involved in the care of the children. Results. During 1992 and 1993, 23 deaths attributed to pertussis were reported to the Centers for Disease Control and Prevention. Cultures for Bordetella pertussis were positive in 18 (90%) of the 20 cases in which it was performed. Twenty (87%) of the 23 children who died were younger than 1 year of age, and 18 (78%) of the children had received no doses of pertussis vaccine. Among 20 children for whom gestational ages were known, 12 (60%) were born at 36 weeks' gestation or earlier; in contrast, 10.7% of live births in the United States in 1992 were at 36 weeks' gestation or earlier. The median age of mothers whose children had fatal pertussis was 20 (range, 14 to 37) years in the 15 cases in which ages were known, compared with the national median age of 26.3 years in 1992. Pneumonia was a complication in all but 1 (96%) of the cases. Seizures occurred in 4 cases (17%), and acute encephalopathy occurred in 3 cases (13%). Conclusions. Pertussis continues to cause serious illness and death in the United States, particularly among infants who are not vaccinated. Preterm delivery and young maternal age may place infants at increased risk of death because of pertussis. Under the current pertussis vaccination schedule, three fourths of the infants who died were too young to have received three doses of pertussis vaccine, the minimum number of doses considered necessary for adequate protection against clinical pertussis. Additional strategies to prevent deaths caused by pertussis in young infants, such as starting infant vaccination at an earlier age and booster doses to adolescents and adults, need to be evaluated.


2019 ◽  
pp. 197-222
Author(s):  
Janet R. Gilsdorf

The success of the conjugate Hib vaccines has been spectacular. Prior to their introduction, an estimated 10,000 cases of Hib meningitis occurred annually in the United States, which was approximately 1 in 300 children. It was even higher among native Alaskan and American Indian children. Since the widespread use of the vaccine, the disease has nearly disappeared in the United States, with only 40 cases in children under age 5 years reported by the Centers for Disease Control and Prevention in 2014. Thus, bacterial meningitis, once a scourge that killed and damaged too many American children is, for the most part, now a bad memory.


2009 ◽  
Vol 7 (4) ◽  
pp. 9
Author(s):  
Atresha Karra, JD ◽  
Emily Cornette, JD

This article focuses on the existing methods for tracking and restricting the spread of communicable diseases, both within United States borders and across nations. It will first describe the roles played by the United States’ Centers for Disease Control and Prevention and the World Health Organization and will then explore how communicable diseases across the world are identified and monitored. This will be followed by a discussion of US and world reporting requirements and methods. Finally, the article will discuss the tactics used by the United States to control the spread of disease.


2016 ◽  
Vol 54 (2) ◽  
pp. 106-111 ◽  
Author(s):  
DeLawnia Comer-HaGans ◽  
Shamly Austin ◽  
Zo Ramamonjiarivelo

Abstract According to 2010 data from the Centers for Disease Control and Prevention (CDC), diabetes is the seventh leading cause of death in the United States. It is assumed that various diabetes interventions are available to help individuals manage this chronic disease, but that is not the case. The literature is scant regarding interventions focused on people with disabilities who have diabetes. The purpose of this article is to review interventions specifically focused on people with disabilities who have diabetes and to discuss the effect of these interventions on this population.


2002 ◽  
Vol 6 (20) ◽  
Author(s):  
C McGarrigle

The United States (US) Centers for Disease Control and Prevention has published new guidelines for the treatment of sexually transmitted diseases (STDs) (1). The guidelines are for physicians and other healthcare providers who prevent and treat sexually transmitted diseases (STDs).


2001 ◽  
Vol 5 (51) ◽  
Author(s):  
R Harling

The Centers for Disease Control and Prevention (CDC) in the United States (US) last week released its plans to cope with a deliberate release of smallpox (1). The plan centres on rapid ring vaccination of the contacts of infected individuals to contain the spread of infection. Mass vaccination in advance of an outbreak will not be used, partly because the risks associated with vaccination outweigh the risks of exposure to smallpox.


Sign in / Sign up

Export Citation Format

Share Document